CiVi Biopharma to Participate in HC Wainwright BioConnect 2021 Conference
CiVi Biopharma to Participate in HC Wainwright BioConnect 2021 Conference News provided by Share this article CHEVY CHASE, Md., Jan. 8, 2021 /PRNewswire/ -- CiVi Biopharma, Inc. ("CiVi" or "the Company"), a privately held company focused on creating novel therapies against diseases where the unmet medical need exists, today announces that Company management will participate in the upcoming HC Wainwright BioConnect 2021 Conference taking place virtually from January 11-14, 2021. Shalom Jacobovitz, Chief Executive Officer of CiVi Biopharma, will deliver a corporate overview in a webcast pr...
Source: prnewswire.com